The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same…
Ce dossier présente un ensemble d'éditoriaux sur le dépistage des cancers du poumon
The United States Preventive Services Task Force (USPSTF) recently updated its recommendation statement regarding lung cancer screening (LCS) using low-dose computed tomography (LDCT). This update was based on a systematic evidence synthesis, including review of more than 220 publications, and informed by extensive decision analysis modeling by the Cancer Intervention and Surveillance Modeling Network (CISNET) Lung Cancer Working Group. As with its 2013 statement, the USPSTF gave LCS a B recommendation, meaning its consensus was that there is moderate certainty that annual screening for lung cancer with LDCT is of moderate net benefit. Key changes from the 2013 statement include expansion of the recommended eligibility criteria to begin screening at age 50 years instead of 55 years and requiring 20 rather than 30 pack-years total firsthand cigarette smoke exposure. There was no change in the remaining recommendations, such as the modality and frequency of screening or when to discontinue LCS, and the USPSTF kept risk-factor eligibility criteria rather than switching to criteria determined by risk model.
JAMA Oncology , éditorial en libre accès, 2020